Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells (Q41978535)
Jump to navigation
Jump to search
scientific article published on April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells |
scientific article published on April 2012 |
Statements
1 reference
Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells (English)
1 reference
1 reference
J Brunet
1 reference
C Oliveras-Ferraros
1 reference
S Cufí
1 reference
B Queralt
1 reference
A Vazquez-Martin
1 reference
B Martin-Castillo
1 reference
R de Llorens
1 reference
J A Menendez
1 reference
1 April 2012
1 reference
1 reference
106
1 reference
1406-1414
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference